Announcing IndieBio SF’s Next Wave – VC-Founder Meetings (June 17 to 21) Learn More

Biomathematica SAS

Unlocking the human microbiome using mathematics


Sebastien Forcioli


Ghjuvan Grimaud

CEO & Co-Founder

Company details

BioMathematica is building a new standard in the microbiome field: an online platform called DryLab, which processes and integrates microbiome-related “omics” data for condition-specific, personalized microbiome models in healthy and disease states. Using artificial intelligence and genome-scale metabolic modeling, this platform is used by biotech and pharma companies for data analysis and diet-microbiome, microbe-microbe and host-microbe interaction simulations. The platform is dedicated to genomics data analysis and to the development of personalized nutrition, prebiotics/probiotics/synbiotics, and therapeutics design and optimization.

Get In Touch with Biomathematica SAS

Please tell us a little bit about yourself and why you'd like to get connected. Biomathematica SAS + SOSV will follow up with you via email.


No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.